Advertisement

Topics

Christopher Knight Capone Company Profile

09:06 EDT 23rd September 2017 | BioPortfolio


News Articles [153 Associated News Articles listed on BioPortfolio]

Knight to Present at the 16th Annual CIBC Eastern Institutional Investor Conference in Montreal

MONTREAL, QUEBEC -- (Marketwired) -- 09/21/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Samira Sakhia, President, i...

Knight to Present at the National Bank Financial Quebec Conference in Toronto

MONTREAL, QUEBEC -- (Marketwired) -- 05/31/17 -- Knight Therapeutics Inc. (TSX: GUD), a leading Canadian specialty pharmaceutical company, announced today that Jeffrey Kadanoff, Chief Financial Offi...

Author Silva Knight’s Newly Released “The Adventures of Prince Peter Platypus” is a Story that Teaches the Importance of Obedience and Forgiveness

(PRWEB) September 10, 2017 “The Adventures of Prince Peter Platypus”: Platty fails to obey his mother’s warnings and ...

Knight to Present at the Jefferies Global Healthcare Conference in New York City

MONTREAL, QUEBEC -- (Marketwired) -- 06/02/17 -- Knight Therapeutics Inc. (TSX: GUD), a leading Canadian specialty pharmaceutical company, announced today that Jonathan Ross Goodman, Chief Executive...

Notice of Knight Therapeutics' Second Quarter 2017 Results Conference Call

MONTREAL, QUEBEC -- (Marketwired) -- 08/03/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, will release its second quarter 2017 financial re...

Christopher William Burke

bmj;357/jun12_6/j2822/FAF1faAfter wide ranging experience of both general and especially endocrine medicine in three London hospitals, as well as a few months in general practice, Christopher William....

Knight Reports First Quarter 2017 Results

MONTREAL, QUEBEC -- (Marketwired) -- 05/11/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today reported financial result...

Knight Therapeutics Inc. announces voting results from the Annual Meeting

MONTREAL, QUEBEC -- (Marketwired) -- 05/10/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Corporation") announced today the voting results from the Annual Meeting of the Shareholders he...

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Christopher James Lucas.

Christopher James Stevenson.

The Knight Stick Trap and Knight Stick Sticky Wraps: New Tools for Stable Fly (Diptera: Muscidae) Management.

Stable fly, Stomoxys calcitrans (L.) (Diptera: Muscidae), management can be difficult, especially in situations where pesticide usage is restricted or disallowed. Traps have been used for monitoring s...

Christopher W. Hess, MD, and Michael S. Okun, MD.

Cryptobenthic reef fishes.

Christopher Goatley and Simon Bran introduce the 'hidden' small fishes found on coral reefs.

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

An-Art Study: Atrioventricular (AV) Node Ablation in Cardiac Resynchronisation Therapy

Cardiac resynchronisation therapy (CRT) is a highly effective treatment option for patients with symptomatic heart failure and electrical intraventricular dyssynchrony, who are unresponsiv...

Companies [30 Associated Companies listed on BioPortfolio]

Christopher Knight Capone

Holland & Knight LLP

Holland & Knight has a "one-firm" structure that enables us to offer service without boundaries. With practice groups and industry-based teams comprised of more than 1200 lawyers and professionals, we...

Adams & Knight, Inc.

Founded in 1988 and winner of the American Marketing Association's Marketer of the Year award five of the past six years, Adams & Knight, Inc. provides a full range of integrated ...

The Christopher and Dana Reeve Foundation

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, i...

Knight Scientific Limited

It has taken 2000 years for a mollusc to travel from the gourmet's table to the scientist's laboratory. The journey started with Pliny in AD 70 and reached its first climax when the luminescent protei...

More Information about "Christopher Knight Capone" on BioPortfolio

We have published hundreds of Christopher Knight Capone news stories on BioPortfolio along with dozens of Christopher Knight Capone Clinical Trials and PubMed Articles about Christopher Knight Capone for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Christopher Knight Capone Companies in our database. You can also find out about relevant Christopher Knight Capone Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record